September 26, 2024

TerraTrust nominated for the DQS Sustainability Award 2024 in the “Sustainable Innovation” category

TerraTrust nominated for the DQS Sustainability Award 2024 in the “Sustainable Innovation” category
Go back

We are pleased to announce significant news: the first sustainable and biodegradable pregnancy test in Europe developed by Zamann Pharma Support, under the Terra Trust house brand, has been nominated for the prestigious DQS Sustainability Award 2024 in the “Sustainable Innovation” category. This nomination is a confirmation of their tireless commitment to environmental protection and sustainable innovation.

Every year, the DQS Sustainability Awards recognize companies that are pioneers in sustainability. It is one of the most important awards in the field of sustainability, recognizing companies, regardless of their size, for their innovative approaches to promoting environmental protection and social responsibility. This nomination is not only a recognition for Terra Trust, but underscores how necessary sustainable solutions have become in all areas of life, including the healthcare industry.

For Terra Trust, this nomination symbolizes much more than just a recognition of their technical innovation. It highlights the growing importance of environmental protection in a sector traditionally characterized by plastic waste and environmentally harmful disposables. Their product represents a new generation of pregnancy tests that protect the environment without compromising on quality or accuracy.

More Information in German / Original News:

Sustainability Award 2024 TerraTrustDownload

Our latest News

discover more
13.2 million euros for new immunotherapies against Ewing sarcomas in children and adolescents

13.2 million euros for new immunotherapies against Ewing sarcomas in children and adolescents

The European research project THEODORA is launching during “Gold September”, the international childhood cancer awareness month. Researchers at the Heidelberg Medical Faculty of Heidelberg University, drawing on their expertise in clinical research and precision oncology at Hopp Children’s Cancer Center Heidelberg (KiTZ), are collaborating with Institut Curie in Paris, Prinses Máxima Centrum in Utrecht, and […]

read more
Light-Based 3D Printing: Innovative “Ink” Enables a Closed-Loop Material Cycle

Light-Based 3D Printing: Innovative “Ink” Enables a Closed-Loop Material Cycle

Heidelberg research team develops a polymer material that can be broken down into its individual components and reused Polymers used for light-based 3D printing are very stable due to their chemical structure, but they are typically hard to recycle. A research team led by Prof. Dr. Eva Blasco, a researcher at the Institute for Molecular […]

read more
Colon Cancer: How Highly Aggressive Tumors Evade the Immune System

Colon Cancer: How Highly Aggressive Tumors Evade the Immune System

Researchers from the German Cancer Research Center (DKFZ) and the HI-STEM* Stem Cell Institute have identified a previously unknown mechanism by which a particularly aggressive form of colon cancer evades the immune system. The findings show that the activation of a key signaling pathway helps cancer cells suppress the immune system, thereby promoting the development […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp